Daniel M. Junius - 21 May 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
Issuer symbol
IDXX
Transactions as of
21 May 2021
Net transactions value
-$1,136,418
Form type
4
Filing time
24 May 2021, 18:15:53 UTC
Previous filing
27 May 2021
Next filing
03 Aug 2021
SEC
View on sec.gov

Key filing fact

Daniel M. Junius filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 24 May 2021.

Key facts

  • This page summarizes Daniel M. Junius's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 24 May 2021, 18:15.

Change

  • Previous filing in this sequence was filed on 27 May 2021.
  • Current net transaction value: -$1,136,418.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

IDXX transaction

Common Stock

Options Exercise

Transaction value
$212,500
Shares
+2,500
Change %
+87%
Price
$85.00
Shares after
5,386
Date
21 May 2021
Ownership
Direct
IDXX transaction

Common Stock

Sale

Transaction value
$1,348,918
Shares
-2,500
Change %
-46%
Price
$539.57
Shares after
2,886
Date
21 May 2021
Ownership
Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

IDXX transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares
-2,500
Change %
-51%
Price
Shares after
2,402
Date
21 May 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$85.00
Footnotes
F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders.
F2 Not applicable.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .